Wellbiotec Balance Sheet Health
Financial Health criteria checks 4/6
Wellbiotec has a total shareholder equity of ₩35.2B and total debt of ₩3.0B, which brings its debt-to-equity ratio to 8.4%. Its total assets and total liabilities are ₩56.3B and ₩21.1B respectively.
Key information
8.4%
Debt to equity ratio
₩2.96b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩11.56b |
| Equity | ₩35.23b |
| Total liabilities | ₩21.10b |
| Total assets | ₩56.33b |
Financial Position Analysis
Short Term Liabilities: A010600's short term assets (₩35.3B) exceed its short term liabilities (₩18.6B).
Long Term Liabilities: A010600's short term assets (₩35.3B) exceed its long term liabilities (₩2.5B).
Debt to Equity History and Analysis
Debt Level: A010600 has more cash than its total debt.
Reducing Debt: A010600's debt to equity ratio has reduced from 15% to 8.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A010600 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A010600 has less than a year of cash runway if free cash flow continues to grow at historical rates of 18.5% each year.